NASDAQ:SGMO   Sangamo Therapeutics, Inc.
SGMO is in the gene editing space. Nice setup as it successfully tested the breakout spot and found support. Now launching higher today off key moving averages. CRSP reports earnings this week so we could see a positive catalyst. I took some May $15 calls today.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.